Novartis delivered strong growth and innovation during the third quarter
Novartis reported total 2018 third quarter net sales grew 6% (+3% USD) over the prior year period. The company reported 2018 third quarter net income declined 18% (-22% USD) due to lower operating income and JV discontinuation. October 18, 2018